secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2024-09-13T23:59:59+00:00
Accession:  0001213900-24-078287
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology secures partial deferral of milestone payment to Dr. Reddy's without penalty
--------------------------------------------------------------------------------

- Milestone payment triggered by FDA approval of LYMPHIR was due Sept 9, 2024; partial deferral granted without penalty.
- All other terms and conditions of the Asset Purchase Agreement remain in full force and effect.
- Further discussions with Dr. Reddy's pending; partial deferral avoids immediate cash outflow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390024078287/0001213900-24-078287-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390024078287/ea0214419-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-078287

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer